EUVIMEDEUVIMED entdecken
Crossref

Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke

Aoming Jin iD, Shukun Wang, Jiejie Li, Mengxing Wang, Jinxi Lin, Hao Li, Xia Meng, Yongjun Wang iD, Yuesong Pan iD

Stroke · 2023-03 · 54 (3) · 759-769

DOI: 10.1161/strokeaha.122.039542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2023-03. Verfasst von Aoming Jin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital (A.J., J. Li, M.W., J. Lin, H.L., X.M., Y.W., Y.P.), Capital Medical University, China. Hauptthemen laut MEDLINE: Insulin Resistance, Ischemic Stroke, Stroke. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insulin resistance is associated with stroke recurrence and poor functional outcomes of nondiabetic patients with ischemic stroke. The study aimed to investigate whether the association between insulin resistance and the prognosis of nondiabetic patients with ischemic stroke was mediated by systematic inflammation.

Methods

Patients with ischemic stroke but without a history of diabetes who were enrolled in CNSR-III (Third China National Stroke Registry) were included in the study and followed up for 1 year after stroke onset. Insulin resistance was determined by using the homeostasis model assessment for insulin resistance (HOMA-IR) method. hs-CRP (high-sensitivity C-reactive protein) and Lp-PLA 2 (lipoprotein-associated phospholipase A 2 ) activity were measured at baseline. The primary outcome was stroke recurrence, and other outcomes included composite vascular events, mortality, and poor functional outcome (modified Rankin Scale score, 3–6). Multivariable Cox or logistic regression analyses were performed to estimate the association between HOMA-IR and the study outcomes. A mediation analysis was performed to examine the relationship between insulin resistance and the study outcomes mediated by systemic inflammation.

Results

Among a total of 3808 nondiabetic patients with ischemic stroke who were included in the study, the median HOMA-IR was 1.79 (interquartile range, 1.05–2.97). After adjustments for potential confounders, higher HOMA-IR quartiles were associated with higher risks of stroke recurrence, ischemic stroke, and composite vascular events, especially in the large artery atherosclerosis subtype. hs-CRP partially mediated the association between the HOMA-IR index and the prognosis of ischemic stroke (mediation proportion, 5.9% for stroke recurrence and 7.5% for composite vascular events). No evidence of Lp-PLA 2 activity mediating the association of insulin resistance with stroke outcomes was observed.

Conclusions

Our study found that insulin resistance was associated with poor clinical outcomes in nondiabetic patients with ischemic stroke, which was partially mediated by hs-CRP with a modest amount.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceIschemic StrokeStrokeHumansC-Reactive Protein1-Alkyl-2-acetylglycerophosphocholine EsterasePrognosisInflammationRisk FactorsBiomarkers

Stichwörter der Autor:innen

C-reactive proteininsulin resistanceischemic strokemediation analysisprognosis

Substanzen

C-Reactive Protein1-Alkyl-2-acetylglycerophosphocholine EsteraseBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Beijing Tiantan Hospital (A.J., J. Li, M.W., J. Lin, H.L., X.M., Y.W., Y.P.), Capital Medical University, China.
  • China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital (A.J., J. Li, M.W., J. Lin, H.L., X.M., Y.W., Y.P.), Capital Medical University, China.
  • The Brain Science Center, Beijing Institute of Basic Medical Sciences, China (S.W.).
  • Advanced Innovation Center for Human Brain Protection (Y.W.), Capital Medical University, China.
  • Research Unit of Artificial Intelligence in Cerebrovascular Disease (Y.W.), Chinese Academy of Sciences, Beijing, China.

ORCID-Profile: Aoming Jin, Yongjun Wang, Yuesong Pan

Zitieren

APA

Jin, A., Wang, S., Li, J., Wang, M., Lin, J., Li, H., Meng, X., Wang, Y., & Pan, Y. (2023). Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke. Stroke, 54(3), 759-769. https://doi.org/10.1161/strokeaha.122.039542

Vancouver

Jin A, Wang S, Li J, Wang M, Lin J, Li H, et al. Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke. Stroke. 2023;54(3):759-769. doi:10.1161/strokeaha.122.039542

BibTeX
@article{Jin2023,
  author = {Jin, Aoming and Wang, Shukun and Li, Jiejie and Wang, Mengxing and Lin, Jinxi and Li, Hao and Meng, Xia and Wang, Yongjun and Pan, Yuesong},
  title = {Mediation of Systemic Inflammation on Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke},
  journal = {Stroke},
  year = {2023},
  volume = {54},
  number = {3},
  pages = {759--769},
  doi = {10.1161/strokeaha.122.039542}
}
Kostenlos starten →